Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation

v3.22.1
Stock-based Compensation
3 Months Ended
Mar. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-based Compensation

NOTE 8 —Stock-based Compensation

 

On January 27, 2022, 415,023 shares of common stock were issued under the 2019 Employee Stock Purchase Plan as payment to three executives for bonuses that relate to the 2021 year. The dollar value of these bonuses was fixed at $254 as of December 31, 2021, and the number of shares issued on January 27, 2022 was determined based on the closing stock price on that date. As of December 31, 2021, the bonus was fully vested and $254 was included in accrued expenses. The stock was issued to the executives on February 4, 2022.

 

Stock-based compensation expense for the three months ended March 31, 2022 is as follows:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Cost of revenues

 

$

11

 

 

$

50

 

Sales and marketing

 

26

 

 

56

 

General and administrative

 

225

 

 

174

 

Research and development

 

21

 

 

16

 

 

 

$

283

 

 

$

296

 

 

 

 

Stock Options:

Stock option activity for the three months ended March 31, 2022, is set forth in the table below and reflects the 1-for-10 Reverse Stock Split that became effective on September 15, 2021:

 

 

 

 

 

 

 

 

 

 

 

Weighted average

 

 

 

 

 

 

 

 

 

 

 

Weighted average

 

 

 

remaining

 

 

 

Aggregate

 

 

 

 

 

 

 

exercise price

 

 

 

contractual life

 

 

 

Intrinsic

 

 

 

Options

 

 

 

per share

 

 

 

(in years)

 

 

 

Value*

 

Outstanding at January 1, 2022

 

95,413

 

 

$

40.00

 

 

 

6.73

 

 

$

0

 

Options granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options forfeited

 

(1,074

)

 

$

23.29

 

 

 

 

 

 

 

 

 

Options expired

 

(1,696

)

 

$

52.87

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2022

 

92,643

 

 

$

39.96

 

 

 

6.15

 

 

$

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2022

 

62,550

 

 

$

43.74

 

 

 

5.51

 

 

$

0

 

 

*The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.

 

 

As of March 31, 2022, there was approximately $1,285 of unamortized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of approximately three years.

Restricted Stock Units:

Restricted stock units’ (“RSU”) activity for the three months ended March 31, 2022, is set forth in the table below and reflects the 1-for-10 Reverse Stock Split that became effective on September 15, 2021:

 

 

 

RSUs

 

Outstanding at January 1, 2022

 

 

347,111

 

Granted

 

 

 

Released

 

 

(125

)

Forfeited

 

 

(23,037

)

Outstanding at March 31, 2022

 

 

323,949